CNIO Arte en ARCO 2024 CNIO Arte 2024 Molecular Chaperones in Cancer and Protein Quality Control Frontiers in Immunomodulation and Cancer Therapy (2nd edition)

Inicio | Eventos | Evaluation of NKG2D chimeric antigen receptor redirected CD45RA- T cells as treatment for pediatric acute leukemia

Evaluation of NKG2D chimeric antigen receptor redirected CD45RA- T cells as treatment for pediatric acute leukemia

Información

Fecha: 20/05/2022
Hora 12:00
Lugar: La Pagoda UAM
Conferenciante Adrián Fernández
Procedencia Former member H12O – CNIO Haematological Malignancies Clinical Research Unit, Clinical Research Programme
Supervised by Lucía Fernández, H12O – CNIO Haematological Malignancies Clinical Research Unit, Clinical Research Programme and Antonio Pérez, La Paz Hospital
Entrada libre hasta completar aforo

Subir